Mats Ohlin
191 – 200 of 223
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B
(
- Contribution to journal › Article
-
Mark
Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase
(
- Contribution to journal › Article
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
(
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
(
- Contribution to journal › Article
-
Mark
Flow cytometric analysis of the stability of antibody production by human × human × mouse heterohybridoma subclones
(
- Contribution to journal › Article
- 1993
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat
(
- Contribution to journal › Article